MEDIFAST, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$386M
Cost of Revenue
$111M
Gross Profit
$275M
R&D
$4M
SG&A
$289M
D&A
$14M
Operating Income
$-14M
EBITDA
$29K
Interest Expense
$6M
Other Income/Expense
$14M
Pretax Income
$-6M
Tax Provision
$13M
Net Income
$-19M
Gross Margin
71.3%
Operating Margin
-3.7%
Net Margin
-4.8%
Effective Tax Rate
-231.1%
Deferred Tax Assets
$0
Deferred Tax Liabilities
$2M
DTA Valuation Allowance
$14M
Tax Credit Carryforwards
—
NOL Carryforwards
$49M
ETR (Continuing Operations)
-231.1%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-58.3%
ETR Foreign Differential (pp)
—
Operating Lease Cost
$5M
Revenue YoY Variation
-36.0%
Income YoY Variation
-593.8%